Interstitial vascular rarefaction and reduced VEGF-A expression in human diabetic nephropathy

Maja T. Lindenmeyer, Matthias Kretzler, Anissa Boucherot, Silvia Berra, Yoshinari Yasuda, Anna Henger, Felix Eichinger, Stefanie Gaiser, Holger Schmid, Maria P. Rastaldi, Robert W. Schrier, Detlef Schlöndorff, Clemens D. Cohen

Research output: Contribution to journalArticle

161 Citations (Scopus)

Abstract

Diabetic nephropathy (DN) is a frequent complication in patients with diabetes. Although the majority of DN models and human studies have focused on glomeruli, tubulointerstitial damage is a major feature of DN and an important predictor of renal dysfunction. This study sought to investigate molecular markers of pathogenic pathways in the renal interstitium of patients with DN. Microdissected tubulointerstitial compartments from biopsies with established DN and control kidneys were subjected to expression profiling. Analysis of candidate genes, potentially involved in DN on the basis of common hypotheses, identified 49 genes with significantly altered expression levels in established DN in comparison with controls. In contrast to some rodent models, the growth factors vascular endothelial growth factor A (VEGF-A) and epidermal growth factor (EGF) showed a decrease in mRNA expression in DN. This was validated on an independent cohort of patients with DN by real-time reverse transcriptase-PCR. Immunohistochemical staining for VEGF-A and EGF also showed a reduced expression in DN. The decrease of renal VEGF-A expression was associated with a reduction in peritubular capillary densities shown by platelet-endothelial cell adhesion molecule-1/CD31 staining. Furthermore, a significant inverse correlation between VEGF-A and proteinuria, as well as EGF and proteinuria, and a positive correlation between VEGF-A and hypoxia-inducible factor-1α mRNA was found. Thus, in human DN, a decrease of VEGF-A, rather than the reported increase as described in some rodent models, may contribute to the progressive disease. These findings and the questions about rodent models in DN raise a note of caution regarding the proposal to inhibit VEGF-A to prevent progression of DN.

Original languageEnglish
Pages (from-to)1765-1776
Number of pages12
JournalJournal of the American Society of Nephrology
Volume18
Issue number6
DOIs
Publication statusPublished - Jun 2007

Fingerprint

Diabetic Nephropathies
Vascular Endothelial Growth Factor A
Blood Vessels
Epidermal Growth Factor
Kidney
Rodentia
Proteinuria
CD31 Antigens
Staining and Labeling
Hypoxia-Inducible Factor 1
Messenger RNA
Genetic Association Studies
Reverse Transcriptase Polymerase Chain Reaction
Real-Time Polymerase Chain Reaction
Intercellular Signaling Peptides and Proteins

ASJC Scopus subject areas

  • Nephrology

Cite this

Lindenmeyer, M. T., Kretzler, M., Boucherot, A., Berra, S., Yasuda, Y., Henger, A., ... Cohen, C. D. (2007). Interstitial vascular rarefaction and reduced VEGF-A expression in human diabetic nephropathy. Journal of the American Society of Nephrology, 18(6), 1765-1776. https://doi.org/10.1681/ASN.2006121304

Interstitial vascular rarefaction and reduced VEGF-A expression in human diabetic nephropathy. / Lindenmeyer, Maja T.; Kretzler, Matthias; Boucherot, Anissa; Berra, Silvia; Yasuda, Yoshinari; Henger, Anna; Eichinger, Felix; Gaiser, Stefanie; Schmid, Holger; Rastaldi, Maria P.; Schrier, Robert W.; Schlöndorff, Detlef; Cohen, Clemens D.

In: Journal of the American Society of Nephrology, Vol. 18, No. 6, 06.2007, p. 1765-1776.

Research output: Contribution to journalArticle

Lindenmeyer, MT, Kretzler, M, Boucherot, A, Berra, S, Yasuda, Y, Henger, A, Eichinger, F, Gaiser, S, Schmid, H, Rastaldi, MP, Schrier, RW, Schlöndorff, D & Cohen, CD 2007, 'Interstitial vascular rarefaction and reduced VEGF-A expression in human diabetic nephropathy', Journal of the American Society of Nephrology, vol. 18, no. 6, pp. 1765-1776. https://doi.org/10.1681/ASN.2006121304
Lindenmeyer, Maja T. ; Kretzler, Matthias ; Boucherot, Anissa ; Berra, Silvia ; Yasuda, Yoshinari ; Henger, Anna ; Eichinger, Felix ; Gaiser, Stefanie ; Schmid, Holger ; Rastaldi, Maria P. ; Schrier, Robert W. ; Schlöndorff, Detlef ; Cohen, Clemens D. / Interstitial vascular rarefaction and reduced VEGF-A expression in human diabetic nephropathy. In: Journal of the American Society of Nephrology. 2007 ; Vol. 18, No. 6. pp. 1765-1776.
@article{4830f247db3f46c78d1914236a4bd9e6,
title = "Interstitial vascular rarefaction and reduced VEGF-A expression in human diabetic nephropathy",
abstract = "Diabetic nephropathy (DN) is a frequent complication in patients with diabetes. Although the majority of DN models and human studies have focused on glomeruli, tubulointerstitial damage is a major feature of DN and an important predictor of renal dysfunction. This study sought to investigate molecular markers of pathogenic pathways in the renal interstitium of patients with DN. Microdissected tubulointerstitial compartments from biopsies with established DN and control kidneys were subjected to expression profiling. Analysis of candidate genes, potentially involved in DN on the basis of common hypotheses, identified 49 genes with significantly altered expression levels in established DN in comparison with controls. In contrast to some rodent models, the growth factors vascular endothelial growth factor A (VEGF-A) and epidermal growth factor (EGF) showed a decrease in mRNA expression in DN. This was validated on an independent cohort of patients with DN by real-time reverse transcriptase-PCR. Immunohistochemical staining for VEGF-A and EGF also showed a reduced expression in DN. The decrease of renal VEGF-A expression was associated with a reduction in peritubular capillary densities shown by platelet-endothelial cell adhesion molecule-1/CD31 staining. Furthermore, a significant inverse correlation between VEGF-A and proteinuria, as well as EGF and proteinuria, and a positive correlation between VEGF-A and hypoxia-inducible factor-1α mRNA was found. Thus, in human DN, a decrease of VEGF-A, rather than the reported increase as described in some rodent models, may contribute to the progressive disease. These findings and the questions about rodent models in DN raise a note of caution regarding the proposal to inhibit VEGF-A to prevent progression of DN.",
author = "Lindenmeyer, {Maja T.} and Matthias Kretzler and Anissa Boucherot and Silvia Berra and Yoshinari Yasuda and Anna Henger and Felix Eichinger and Stefanie Gaiser and Holger Schmid and Rastaldi, {Maria P.} and Schrier, {Robert W.} and Detlef Schl{\"o}ndorff and Cohen, {Clemens D.}",
year = "2007",
month = "6",
doi = "10.1681/ASN.2006121304",
language = "English",
volume = "18",
pages = "1765--1776",
journal = "Journal of the American Society of Nephrology : JASN",
issn = "1046-6673",
publisher = "American Society of Nephrology",
number = "6",

}

TY - JOUR

T1 - Interstitial vascular rarefaction and reduced VEGF-A expression in human diabetic nephropathy

AU - Lindenmeyer, Maja T.

AU - Kretzler, Matthias

AU - Boucherot, Anissa

AU - Berra, Silvia

AU - Yasuda, Yoshinari

AU - Henger, Anna

AU - Eichinger, Felix

AU - Gaiser, Stefanie

AU - Schmid, Holger

AU - Rastaldi, Maria P.

AU - Schrier, Robert W.

AU - Schlöndorff, Detlef

AU - Cohen, Clemens D.

PY - 2007/6

Y1 - 2007/6

N2 - Diabetic nephropathy (DN) is a frequent complication in patients with diabetes. Although the majority of DN models and human studies have focused on glomeruli, tubulointerstitial damage is a major feature of DN and an important predictor of renal dysfunction. This study sought to investigate molecular markers of pathogenic pathways in the renal interstitium of patients with DN. Microdissected tubulointerstitial compartments from biopsies with established DN and control kidneys were subjected to expression profiling. Analysis of candidate genes, potentially involved in DN on the basis of common hypotheses, identified 49 genes with significantly altered expression levels in established DN in comparison with controls. In contrast to some rodent models, the growth factors vascular endothelial growth factor A (VEGF-A) and epidermal growth factor (EGF) showed a decrease in mRNA expression in DN. This was validated on an independent cohort of patients with DN by real-time reverse transcriptase-PCR. Immunohistochemical staining for VEGF-A and EGF also showed a reduced expression in DN. The decrease of renal VEGF-A expression was associated with a reduction in peritubular capillary densities shown by platelet-endothelial cell adhesion molecule-1/CD31 staining. Furthermore, a significant inverse correlation between VEGF-A and proteinuria, as well as EGF and proteinuria, and a positive correlation between VEGF-A and hypoxia-inducible factor-1α mRNA was found. Thus, in human DN, a decrease of VEGF-A, rather than the reported increase as described in some rodent models, may contribute to the progressive disease. These findings and the questions about rodent models in DN raise a note of caution regarding the proposal to inhibit VEGF-A to prevent progression of DN.

AB - Diabetic nephropathy (DN) is a frequent complication in patients with diabetes. Although the majority of DN models and human studies have focused on glomeruli, tubulointerstitial damage is a major feature of DN and an important predictor of renal dysfunction. This study sought to investigate molecular markers of pathogenic pathways in the renal interstitium of patients with DN. Microdissected tubulointerstitial compartments from biopsies with established DN and control kidneys were subjected to expression profiling. Analysis of candidate genes, potentially involved in DN on the basis of common hypotheses, identified 49 genes with significantly altered expression levels in established DN in comparison with controls. In contrast to some rodent models, the growth factors vascular endothelial growth factor A (VEGF-A) and epidermal growth factor (EGF) showed a decrease in mRNA expression in DN. This was validated on an independent cohort of patients with DN by real-time reverse transcriptase-PCR. Immunohistochemical staining for VEGF-A and EGF also showed a reduced expression in DN. The decrease of renal VEGF-A expression was associated with a reduction in peritubular capillary densities shown by platelet-endothelial cell adhesion molecule-1/CD31 staining. Furthermore, a significant inverse correlation between VEGF-A and proteinuria, as well as EGF and proteinuria, and a positive correlation between VEGF-A and hypoxia-inducible factor-1α mRNA was found. Thus, in human DN, a decrease of VEGF-A, rather than the reported increase as described in some rodent models, may contribute to the progressive disease. These findings and the questions about rodent models in DN raise a note of caution regarding the proposal to inhibit VEGF-A to prevent progression of DN.

UR - http://www.scopus.com/inward/record.url?scp=34249901258&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34249901258&partnerID=8YFLogxK

U2 - 10.1681/ASN.2006121304

DO - 10.1681/ASN.2006121304

M3 - Article

C2 - 17475821

AN - SCOPUS:34249901258

VL - 18

SP - 1765

EP - 1776

JO - Journal of the American Society of Nephrology : JASN

JF - Journal of the American Society of Nephrology : JASN

SN - 1046-6673

IS - 6

ER -